EPIGENESIS PHARMACEUTICALS Trademark

Trademark Overview


On Thursday, January 12, 2006, a trademark application was filed for EPIGENESIS PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the EPIGENESIS PHARMACEUTICALS trademark a serial number of 78790767. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 11, 2010. This trademark is owned by Epigenesis Pharmaceuticals, LLC. The EPIGENESIS PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

medical diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasconconstriction, inflammation, allergies, impeded respiration, acute respiratory...
epigenesis pharmaceuticals

General Information


Serial Number78790767
Word MarkEPIGENESIS PHARMACEUTICALS
Filing DateThursday, January 12, 2006
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 11, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 19, 2006

Trademark Statements


Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and Servicesmedical diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasconconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ARDS), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating supra ventricular tachycardia (SVT), adenosine stress tests, infantile respiratory distress syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconcontriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostate

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 18, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEpigenesis Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCranbury, NJ 08512

Party NameEpigenesis Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCranbury, NJ 08512

Trademark Events


Event DateEvent Description
Monday, January 11, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 11, 2010ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 30, 2009EXTENSION 5 GRANTED
Monday, June 8, 2009EXTENSION 5 FILED
Tuesday, June 30, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 8, 2009TEAS EXTENSION RECEIVED
Monday, December 1, 2008EXTENSION 4 GRANTED
Monday, December 1, 2008EXTENSION 4 FILED
Monday, December 1, 2008TEAS EXTENSION RECEIVED
Wednesday, June 4, 2008EXTENSION 3 GRANTED
Wednesday, June 4, 2008EXTENSION 3 FILED
Wednesday, June 4, 2008TEAS EXTENSION RECEIVED
Monday, December 3, 2007EXTENSION 2 GRANTED
Monday, December 3, 2007EXTENSION 2 FILED
Monday, December 3, 2007TEAS EXTENSION RECEIVED
Tuesday, June 5, 2007EXTENSION 1 GRANTED
Tuesday, June 5, 2007EXTENSION 1 FILED
Tuesday, June 5, 2007TEAS EXTENSION RECEIVED
Tuesday, December 12, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 19, 2006PUBLISHED FOR OPPOSITION
Wednesday, August 30, 2006NOTICE OF PUBLICATION
Thursday, July 27, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, July 21, 2006ASSIGNED TO LIE
Monday, July 17, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 13, 2006EXAMINER'S AMENDMENT ENTERED
Thursday, July 13, 2006EXAMINERS AMENDMENT E-MAILED
Thursday, July 13, 2006EXAMINERS AMENDMENT -WRITTEN
Thursday, June 29, 2006ASSIGNED TO EXAMINER
Wednesday, January 18, 2006NEW APPLICATION ENTERED IN TRAM